Kidney disease is a broad term for any condition that damages the kidneys and reduces their ability to filter waste and excess fluid from the blood. The most common form, chronic kidney disease (CKD), progresses through five stages based on how much filtering capacity remains, and fewer than five percent of people in the early stages realize they have it.1JAMA. Chronic Kidney Disease Diagnosis and Management: A Review Because the kidneys compensate quietly for a long time before symptoms appear, the disease often advances well before anyone thinks to check.
What Healthy Kidneys Actually Do
Your kidneys are two fist-sized organs tucked behind your ribcage. Each one contains roughly a million tiny filtering units called nephrons. Every day, these nephrons process about 150 liters of blood, pulling out waste products, balancing electrolytes like sodium and potassium, regulating blood pressure through hormone signals, and sending excess water to the bladder as urine. They also help produce the active form of vitamin D and a hormone called erythropoietin that tells your bone marrow to make red blood cells. When enough nephrons are damaged or destroyed, all of those jobs suffer.
Why Most People Do Not Know They Have It
Early kidney disease is notoriously silent. In stages one and two, your remaining nephrons work harder to pick up the slack, and blood tests can still look relatively normal. You feel fine. By stage three, subtle signs may start appearing, but they are easy to blame on other things: fatigue, mildly swollen ankles, foamy-looking urine, or getting up to urinate more often at night. None of those screams “kidney problem” to most people.
As the disease advances into stages four and five, symptoms become harder to ignore. Nausea, persistent itching, muscle cramps, loss of appetite, difficulty concentrating, and significant swelling in the legs or around the eyes all reflect the body’s growing inability to clear waste. By the time someone feels truly sick, a large share of kidney function has already been lost. This is why screening in at-risk groups matters so much: the disease is far easier to slow down than to reverse.
Monitoring also becomes important because CKD triggers a cascade of complications that do not obviously point to the kidneys. These include high potassium levels, a buildup of acid in the blood, rising phosphorus, vitamin D deficiency, weakened bones, and anemia from declining erythropoietin production.1JAMA. Chronic Kidney Disease Diagnosis and Management: A Review
The Leading Causes
Two conditions account for the majority of chronic kidney disease cases worldwide: diabetes and high blood pressure. After those, autoimmune diseases and inherited conditions round out the list.
Diabetes
Persistently high blood sugar damages the delicate blood vessels inside the kidney’s filtering units. Over time, hyperglycemia triggers inflammation and the production of harmful molecules that alter the structure of both the glomerulus (the kidney’s miniature filter) and the surrounding tubules.2PubMed Central. The Mechanism of Hyperglycemia-Induced Renal Cell Injury in Diabetic Nephropathy Disease: An Update The result is a slow leak of protein into the urine, followed by progressive scarring. Diabetic kidney disease is the single most common reason people end up needing dialysis.
High Blood Pressure
Uncontrolled hypertension batters the small arteries feeding the kidneys. The vessel walls thicken and stiffen, gradually choking off blood flow to the nephrons. A study of patients with hypertensive kidney damage found that in roughly two thirds of cases, the high-blood-pressure-related scarring was the only abnormality explaining their declining kidney function.3Hypertension. Hypertensive nephrosclerosis as a relevant cause of chronic renal failure The relationship also runs in reverse: damaged kidneys lose their ability to regulate blood pressure, which accelerates the damage further.
Autoimmune and Inflammatory Diseases
In conditions like lupus, the immune system produces antibodies that form complexes and deposit in kidney tissue, sparking inflammation in the glomeruli.4PubMed Central. Pathogenesis of kidney disease in systemic lupus erythematosus Other forms of glomerulonephritis arise from infections, drug reactions, or immune processes that are harder to pin down. These causes tend to affect younger patients more often than diabetes or hypertension do.
Polycystic Kidney Disease
Polycystic kidney disease (PKD) is the most common inherited cause of kidney failure. Mutations in two genes, PKD1 and PKD2, disrupt a signaling complex on kidney cells. When function of that complex drops below a certain threshold, fluid-filled cysts begin forming and expanding throughout the kidney, crowding out healthy tissue over decades.5PubMed Central. Mechanisms of Cyst Development in Polycystic Kidney Disease Because the cysts grow slowly, many people with PKD do not reach kidney failure until middle age, but the disease can be detected much earlier with imaging.
The Five Stages of Chronic Kidney Disease
Doctors classify CKD using a five-stage system based on the glomerular filtration rate, or GFR, which estimates how many milliliters of blood your kidneys can filter per minute. The framework, published by the National Kidney Foundation, also factors in markers of kidney damage like protein in the urine.6Annals of Internal Medicine. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification
- Stage 1: GFR is 90 or above. The kidneys filter normally, but there is evidence of damage such as protein in the urine or structural abnormalities on imaging.
- Stage 2: GFR is 60 to 89. A mild drop in filtration, usually still without symptoms.
- Stage 3: GFR is 30 to 59. Often split into 3a (45–59) and 3b (30–44). Waste products start building up, and complications like anemia or bone problems may begin.
- Stage 4: GFR is 15 to 29. A severe reduction. Symptoms are common, and preparation for dialysis or transplant evaluation usually begins.
- Stage 5: GFR falls below 15. This is end-stage kidney disease, where the kidneys can no longer sustain life without dialysis or a transplant.
These stages are not destiny. Many people live in stage 2 or 3 for years or even decades without ever reaching stage 5, especially if the underlying cause is managed. The speed of progression depends heavily on what is driving the disease, how well blood pressure and blood sugar are controlled, and whether medications that protect the kidney are started early.
When Kidney Damage Strikes Suddenly
Not all kidney disease is chronic. Acute kidney injury (AKI) is a rapid decline in kidney function that develops over hours to days. Common triggers include severe dehydration, major surgery, sepsis, certain medications like high-dose anti-inflammatory drugs, and contrast dye used in medical imaging. Unlike CKD, AKI is sometimes fully reversible if treated quickly.
The two conditions are more intertwined than doctors once believed. AKI is now recognized as a major risk factor for developing CKD later on, and people who already have CKD are at much higher risk of experiencing an acute episode.7PubMed Central. Acute kidney injury and chronic kidney disease as interconnected syndromes Even an episode of AKI that appears to resolve completely can leave behind microscopic scarring that reduces the kidney’s long-term reserves. For someone with borderline kidney function, a single bout of AKI can tip the balance toward progressive disease.
How Kidney Disease Is Detected
Screening for CKD relies on two simple tests: a blood draw to estimate GFR from creatinine levels, and a urine sample to check for albumin, a protein that healthy kidneys keep out of the urine. The National Kidney Foundation guidelines recommend screening in people with diabetes, hypertension, a family history of kidney disease, and those over sixty.6Annals of Internal Medicine. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Population-based screening studies have found that a meaningful share of participants had previously undetected kidney problems. In one such study, albumin in the urine was confirmed in about twelve percent of participants, and at least nine percent had a GFR below 60, placing them in stage 3 or worse.8American Journal of Nephrology. Early Detection of Chronic Kidney Disease: Results of the PolNef Study
If screening turns up abnormalities, an ultrasound can check kidney size and structure, and additional blood work helps identify complications like anemia or electrolyte disturbances. A kidney biopsy, where a small tissue sample is examined under a microscope, is reserved for cases where the cause is unclear or a specific treatment decision hinges on the type of damage present.
How Kidney Disease Affects the Heart
Cardiovascular disease is the leading cause of death in people with CKD, and the relationship goes both ways. Damaged kidneys retain fluid and sodium, raising blood pressure. They also accumulate waste products called uremic toxins that inflame blood vessel walls and accelerate hardening of the arteries. This interconnected deterioration is sometimes called cardiorenal syndrome.9PubMed Central. A Systematic Review of Uremic Toxin Concentrations and Cardiovascular Risk Markers in Pediatric Chronic Kidney Disease The risk climbs steeply with each advancing stage of CKD. In fact, for many patients with moderate kidney disease, the greater statistical threat is a heart attack or stroke rather than progression to dialysis.
The Gut-Kidney Connection
One of the more surprising developments in kidney research is how much the gut microbiome matters. As kidney function declines, urea and other waste products flood into the intestines, shifting the balance of gut bacteria. Beneficial species that produce short-chain fatty acids decline, while bacteria that generate uremic toxins flourish.10Clinical Science. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins Compounds like indoxyl sulfate, p-cresyl sulfate, and trimethylamine-N-oxide (TMAO) accumulate in the blood, where they promote inflammation, oxidative damage, and vascular calcification.
Making matters worse, CKD itself damages the intestinal lining, loosening the tight junctions between gut cells and allowing even more toxins to leak into the bloodstream.11PubMed Central. The Impact of CKD on Uremic Toxins and Gut Microbiota Higher blood levels of these gut-derived toxins are associated with more cardiovascular events and higher mortality in the CKD population.10Clinical Science. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins This creates a feedback loop: failing kidneys worsen the gut environment, and the gut sends back a wave of toxins that damage the kidneys and other organs further. Research into probiotics, prebiotics, and dietary strategies aimed at breaking this cycle is active but still in relatively early stages.
Treatment and Slowing Progression
There is no cure for most forms of chronic kidney disease, but treatment can dramatically slow the decline and delay or even prevent the need for dialysis.
Medications
Blood pressure control is the cornerstone. ACE inhibitors and angiotensin receptor blockers reduce pressure inside the glomeruli and cut the amount of protein leaking into the urine, both of which protect the kidneys. A newer class of drugs called SGLT2 inhibitors, originally developed for diabetes, has emerged as a major disease-modifying therapy for CKD regardless of whether a patient has diabetes. These drugs reduce pressure inside the kidney’s filtering units through a mechanism that is independent of their blood-sugar-lowering effect.12PubMed Central. Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations Their introduction has been one of the biggest advances in kidney care in decades.
Dialysis
When kidneys can no longer keep up, dialysis takes over the filtering job. Hemodialysis routes blood through an external machine several times a week, typically at a dialysis center, though home setups exist. Peritoneal dialysis uses the lining of the abdominal cavity as a natural filter, with fluid cycled in and out through a catheter, often overnight. Both approaches sustain life, but neither replaces the full range of kidney functions, and quality of life on dialysis varies widely from person to person.
Transplantation
A kidney transplant from a living or deceased donor offers the best outcomes for people with end-stage disease, providing longer life expectancy and better quality of life than dialysis.13Journal of the American Society of Nephrology. Kidney Transplantation in the Elderly: A Decision Analysis The catch is organ availability: wait lists in many countries stretch for years, and the surgery itself carries upfront risks. Recipients also need lifelong immunosuppressive medication to prevent rejection, which brings its own side effects and infection risks.
Born With Fewer Filters
A less well-known risk factor for kidney disease has nothing to do with what happens in adulthood. The number of nephrons you are born with varies enormously, ranging roughly from about 200,000 to over two million per kidney. People born with fewer nephrons start life with less filtration reserve, and that deficit becomes increasingly consequential with age.
Low birth weight, preterm birth, and restricted growth in the womb are all linked to lower nephron counts.14PubMed. Clinical consequences of developmental programming of low nephron number Impaired kidney development during pregnancy has been identified as a powerful risk factor for both hypertension and CKD later in life, because it lowers the starting GFR and speeds the rate at which primary kidney diseases progress.15PubMed. Prenatal programming-effects on blood pressure and renal function The hypertension that results from too few nephrons then compounds the problem, adding hemodynamic stress to kidneys that were already stretched thin.
From an evolutionary perspective, this trade-off may not be accidental. One theory proposes that when a developing fetus faces nutritional stress, the body prioritizes brain growth over kidney development, a strategy that works well enough through reproductive years but raises the prevalence of CKD in later adulthood.16PubMed Central. Bioenergetic Evolution Explains Prevalence of Low Nephron Number at Birth: Risk Factor for CKD This means maternal nutrition and prenatal care have consequences that extend decades into a child’s future kidney health.
Genetic Risk and Health Disparities
Chronic kidney disease does not affect all populations equally, and genetics explains part of the gap. One of the starkest examples involves variants in the APOL1 gene, carried predominantly by people of West African descent. These variants originally spread because they protect against a lethal form of African sleeping sickness, but they come with a serious trade-off: people who inherit high-risk versions of the gene in both copies face dramatically elevated odds of several kidney diseases. The risk increase is roughly seven to tenfold for hypertension-related kidney failure, about seventeen-fold for a scarring disease called focal segmental glomerulosclerosis, and far higher still for HIV-associated kidney disease.17PubMed Central. APOL1 and APOL1-Associated Kidney Disease: A Common Disease, an Unusual Disease Gene
Case-control studies confirm that African Americans with two copies of APOL1 risk variants face increased risk for both hypertension-attributed end-stage kidney disease and focal segmental glomerulosclerosis.18PubMed Central. Population-based risk assessment of APOL1 on renal disease Carrying the variants does not guarantee kidney disease, since most carriers never develop it. But it does mean that a “second hit,” whether from uncontrolled blood pressure, a viral infection, or another inflammatory insult, is far more likely to trigger severe kidney damage. Understanding APOL1 has reshaped thinking about racial disparities in kidney disease, shifting the conversation from purely socioeconomic explanations toward a more nuanced picture that includes biology.
How Kidney Disease Progresses at the Tissue Level
Regardless of whether the initial trigger is diabetes, high blood pressure, an immune attack, or something else, advanced CKD converges on a common pathway: progressive scarring, or fibrosis, that eventually involves all structures of the kidney. The initial injury activates a self-reinforcing cycle in which inflammatory signals, growth factors, and hormonal systems perpetuate further damage even after the original insult has been treated.19PubMed Central. Mechanisms of progression of chronic kidney disease One reason aggressive blood-pressure control is so important is that it interrupts this cycle at one of its strongest entry points: the renin-angiotensin-aldosterone system, a hormonal cascade the kidneys themselves use to regulate blood pressure. When that system is chronically overactivated, it drives scarring in both the glomeruli and the surrounding tissue.
Protein leaking into the urine is not just a symptom of this process; it actively contributes to it. Filtered proteins are toxic to the tubular cells that line the kidney’s drainage system, promoting local inflammation and fibrosis independent of what is happening in the glomeruli. This helps explain why reducing proteinuria with medication is one of the most reliable ways to slow CKD progression.
Pig Kidneys and the Future of Transplant
The shortage of donor kidneys has pushed researchers toward a once-unthinkable solution: transplanting kidneys from genetically engineered pigs into humans. Using gene-editing tools, scientists have been able to remove pig genes that trigger immediate immune rejection and insert human genes that help the transplanted organ coexist with the recipient’s immune system.20PubMed Central. Future Therapy for End-Stage Kidney Failure: Gene-Edited Pig Kidney Xenotransplantation Early clinical attempts have demonstrated that these modified pig kidneys can produce urine and filter waste in a human body, though long-term outcomes remain unknown and the procedures are still experimental. If the approach proves durable, it could fundamentally change the math for end-stage kidney disease by eliminating the years-long wait for a human donor organ.